Clinical Trial Update: Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial is planned to evaluate the safety and efficacy of CYWC628, human dermal fibroblast spheroids, for refractory diabetic foot ulcers compared wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• CYWC628 (Human Dermal Fibroblast Spheroids) (CYWC628)

Snippet

Sponsor: FibroBiologics | Conditions: Diabetic Foot Ulcer (DFU) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING